Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 4 days ago

Bioventus Inc.: BROWN ADVISORY INC discloses a stake of more than 5% (Schedule 13G)

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 13 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Brown Advisory Inc. disclosed a stake exceeding 5% in Bioventus Inc. via a Schedule 13G filing with the SEC (accession 0001345929-26-000044). The passive-investor disclosure signals a significant institutional position in the medical device maker. The exact share count and percentage were not specified in the filing summary. Investors will watch for further 13G amendments and Bioventus's next quarterly update for clarity on the holder's position.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Bioventus Inc., Brown Advisory Inc.